Ledger.Open graph →
SEC Form D · Amendment · filed May 22, 2020

Therini Bio, Inc

Offering
$9.4M
Sold
$9.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Leslie Schulze · South San Francisco, CAExecLaurence Barker · London, United KingdomDirectorDaniel Burgess · Waltham, MAExec · DirectorAikaterini Akasoglou · SAN FRANCISCO, CADirectorJeffrey Stavenhagen, Ph.D · South San Francisco, CAExecTracy Saxton · Bernardsville, NJDirectorMichael Ross · Foster City, CADirectorAikaterini Akasoglou · SAN FRANCISCO, CADirectorLeslie Schulze · South San Francisco, CAExecLaurence Barker · London, United KingdomDirectorJeffrey Stavenhagen, Ph.D · South San Francisco, CAExecDaniel Burgess · Waltham, MAExec · DirectorTracy Saxton · San Francisco, CADirectorMichael Ross · Chagrin Falls, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗